Cordlife Group Limited (CLIFF)
USD 0.12
(-8.61%)
USD 0.12
(-8.61%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 34.56 Million SGD | 5.91% |
| 2022 | 35.96 Million USD | 38.45% |
| 2021 | 25.97 Million SGD | -6.35% |
| 2020 | 27.74 Million SGD | -11.52% |
| 2019 | 31.35 Million SGD | -26.51% |
| 2018 | 42.66 Million SGD | 0.31% |
| 2017 | 42.53 Million SGD | 12.89% |
| 2016 | 37.67 Million SGD | -0.15% |
| 2015 | 37.73 Million SGD | 46.5% |
| 2014 | 25.75 Million SGD | -1.63% |
| 2013 | 26.18 Million SGD | 45.49% |
| 2012 | 17.99 Million SGD | 12.5% |
| 2011 | 15.99 Million SGD | 44.77% |
| 2010 | 11.05 Million SGD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 Q4 | 19.32 Million USD | 188.92% |
| 2023 Q1 | 6.72 Million SGD | -64.33% |
| 2023 FY | 38.09 Million SGD | 5.91% |
| 2023 Q2 | 18.07 Million USD | 168.56% |
| 2023 Q3 | 6.68 Million SGD | -62.99% |
| 2022 Q1 | 6.06 Million SGD | -65.9% |
| 2022 Q2 | 16.33 Million USD | 169.28% |
| 2022 Q3 | 6.18 Million SGD | -62.12% |
| 2022 FY | 35.96 Million USD | 38.45% |
| 2022 Q4 | 18.86 Million USD | 204.87% |
| 2021 Q4 | 17.79 Million SGD | 176.05% |
| 2021 Q3 | 6.44 Million SGD | -62.38% |
| 2021 FY | 25.97 Million SGD | -6.35% |
| 2021 Q1 | 6.33 Million SGD | -65.45% |
| 2021 Q2 | 17.13 Million SGD | 170.56% |
| 2020 Q1 | 6.54 Million SGD | -42.36% |
| 2020 Q4 | 18.33 Million SGD | 216.0% |
| 2020 FY | 27.74 Million SGD | -11.52% |
| 2020 Q3 | 5.8 Million SGD | -68.5% |
| 2020 Q2 | 18.41 Million SGD | 181.37% |
| 2019 Q1 | 10.25 Million SGD | 36.47% |
| 2019 FY | 31.35 Million SGD | -26.51% |
| 2019 Q4 | 11.35 Million SGD | 6.19% |
| 2019 Q3 | 10.69 Million SGD | -0.3% |
| 2019 Q2 | 10.72 Million SGD | 4.55% |
| 2018 Q3 | 10.79 Million SGD | -3.22% |
| 2018 Q2 | 11.15 Million SGD | 1.36% |
| 2018 Q4 | 7.51 Million SGD | -30.35% |
| 2018 FY | 42.66 Million SGD | 0.31% |
| 2018 Q1 | 11 Million SGD | 10.11% |
| 2017 Q2 | 10.48 Million SGD | 5.53% |
| 2017 Q3 | 10.39 Million SGD | -0.87% |
| 2017 FY | 42.53 Million SGD | 12.89% |
| 2017 Q1 | 9.93 Million SGD | 6.24% |
| 2017 Q4 | 9.99 Million SGD | -3.89% |
| 2016 Q4 | 9.35 Million SGD | 0.81% |
| 2016 Q2 | 12.52 Million SGD | 41.8% |
| 2016 FY | 37.67 Million SGD | -0.15% |
| 2016 Q1 | 8.83 Million SGD | 0.0% |
| 2016 Q3 | 9.27 Million SGD | -25.93% |
| 2015 Q1 | 7.66 Million SGD | -8.99% |
| 2015 Q4 | 8.83 Million SGD | 7.42% |
| 2015 Q3 | 8.22 Million SGD | -25.74% |
| 2015 Q2 | 11.07 Million SGD | 44.53% |
| 2015 FY | 37.73 Million SGD | 46.5% |
| 2014 FY | 25.75 Million SGD | -1.63% |
| 2014 Q4 | 8.41 Million SGD | 13.86% |
| 2014 Q3 | 7.39 Million SGD | -0.79% |
| 2014 Q2 | 7.45 Million SGD | 16.98% |
| 2014 Q1 | 6.37 Million SGD | 2.13% |
| 2013 Q1 | 4.06 Million SGD | -5.16% |
| 2013 FY | 26.18 Million SGD | 45.49% |
| 2013 Q3 | 6.12 Million SGD | 0.02% |
| 2013 Q2 | 6.12 Million SGD | 50.74% |
| 2013 Q4 | 6.23 Million SGD | 1.86% |
| 2012 Q1 | 4.59 Million SGD | 22.55% |
| 2012 FY | 17.99 Million SGD | 12.5% |
| 2012 Q2 | 4.25 Million SGD | -7.39% |
| 2012 Q3 | 3.5 Million SGD | -17.75% |
| 2012 Q4 | 4.28 Million SGD | 22.3% |
| 2011 Q4 | 3.75 Million SGD | 6.17% |
| 2011 Q2 | 3.19 Million SGD | 11.89% |
| 2011 Q1 | 2.85 Million SGD | 0.0% |
| 2011 FY | 15.99 Million SGD | 44.77% |
| 2011 Q3 | 3.53 Million SGD | 10.78% |
| 2010 FY | 11.05 Million SGD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Bio Medica Corporation | 1.04 Million USD | -3194.757% |
| Arrayit Corporation | 6.19 Million USD | -457.67% |
| Atlantic International Corp. | 5.57 Million USD | -519.582% |
| Biocept, Inc. | 29.4 Million USD | -17.554% |
| Bioqual, Inc. | 7.44 Million USD | -363.996% |
| CardioGenics Holdings Inc | 772.14 Thousand USD | -4376.12% |
| DermTech, Inc. | 104.01 Million USD | 66.772% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 166.5 Million USD | 79.242% |
| HTG Molecular Diagnostics, Inc. | 22.62 Million USD | -52.769% |
| iMD Companies, Inc. | 151.8 Thousand USD | -22666.766% |
| IDenta Corp. | 662.97 Thousand USD | -5113.168% |
| Interpace Biosciences, Inc. | 20.23 Million USD | -70.828% |
| Integrative Health Technologies, Inc. | 38.88 Thousand USD | -88791.747% |
| InVitro International | 661.32 Thousand USD | -5126.183% |
| Lumos Diagnostics Holdings Limited | 7.09 Million USD | -386.926% |
| Many Bright Ideas Technologies Inc. | 58.11 Thousand USD | -59374.807% |
| Medical Imaging Corp. | 1.91 Million USD | -1707.481% |
| NovelStem International Corp. | 3.53 Million USD | -876.935% |
| Optigenex Inc. | 1.28 Million USD | -2583.658% |
| PharmChem, Inc. | 2.93 Million USD | -1079.096% |
| Proteome Sciences plc | 3.26 Million USD | -957.589% |
| Response Genetics, Inc | 25.31 Million USD | -36.506% |
| Rennova Health, Inc. | 7.67 Million USD | -350.156% |
| RushNet, Inc. | 1.78 Million USD | -1831.572% |
| ScreenPro Security Inc. | 3.23 Million USD | -967.086% |
| Stella Diagnostics Inc. | 11.42 Million USD | -202.46% |
| StageZero Life Sciences Ltd. | 7.34 Million USD | -370.679% |
| Todos Medical Ltd. | 14.05 Million USD | -145.853% |